| __timestamp | Amneal Pharmaceuticals, Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 785623000 | 8263500000 |
| Thursday, January 1, 2015 | 866280000 | 10498800000 |
| Friday, January 1, 2016 | 1018225000 | 9674000000 |
| Sunday, January 1, 2017 | 1033654000 | 8724000000 |
| Monday, January 1, 2018 | 1662991000 | 8380000000 |
| Tuesday, January 1, 2019 | 1626373000 | 8601000000 |
| Wednesday, January 1, 2020 | 1992523000 | 8027000000 |
| Friday, January 1, 2021 | 2093669000 | 8434000000 |
| Saturday, January 1, 2022 | 2212304000 | 8124000000 |
| Sunday, January 1, 2023 | 2393607000 | 8757000000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, revenue growth is a key indicator of success. Over the past decade, Amneal Pharmaceuticals, Inc. and Bausch Health Companies Inc. have been vying for market dominance. From 2014 to 2023, Amneal's revenue surged by approximately 205%, starting from $785 million to nearly $2.4 billion. In contrast, Bausch Health, despite its larger revenue base, experienced a more modest growth of about 6%, from $8.3 billion to $8.8 billion.
Amneal's impressive growth trajectory highlights its strategic market positioning and expansion efforts. Meanwhile, Bausch Health's steady revenue reflects its established presence and consistent performance in the industry. This revenue showdown not only underscores the dynamic nature of the pharmaceutical sector but also provides insights into the strategic maneuvers of these industry giants.
Who Generates More Revenue? Johnson & Johnson or Bausch Health Companies Inc.
AbbVie Inc. vs Bausch Health Companies Inc.: Examining Key Revenue Metrics
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Alnylam Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Bio-Techne Corporation or Bausch Health Companies Inc.: Who Leads in Yearly Revenue?
Exelixis, Inc. and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Jazz Pharmaceuticals plc or Bausch Health Companies Inc.?
Revenue Insights: Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Performance Compared
Amneal Pharmaceuticals, Inc. vs MorphoSys AG: Examining Key Revenue Metrics
Amneal Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Amneal Pharmaceuticals, Inc. and Novavax, Inc. Performance Compared
Annual Revenue Comparison: Veracyte, Inc. vs Bausch Health Companies Inc.